Page 15 - Eric Lenze News Today : Breaking News, Live Updates & Top Stories | Vimarsana

email article Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene. MedPage Today explores how the old antidepressant has made its way to the COVID spotlight. Fluvoxamine and the COVID Early Treatment Fund Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). According to its founder, serial tech entrepreneur Steve...

Courtesy of Steve Kirsch Los Altos Hills resident Steve Kirsch funded research into the drug fluvoxamine as a treatment for COVID-19. So far, doctors have failed to share his sense of urgency. Steve Kirsch is baffled. He’s discovered a common medication that’s highly effective in minimizing the impacts of COVID-19 – two studies have proven so. But the mainstream medical community refuses to acknowledge its efficacy pending a third, much larger trial that would involve 1,100 participants and take until June to complete. That’s time many COVID patients don’t have. “It’s so tragic ...

The race to find vaccines for COVID-19 has dominated the headlines, but there's been less news about how to keep people with COVID out of the hospital. Tonight, we're going to tell you a story about one possible treatment. It's called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder. Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine as a possible tool to keep newly diagnosed COVID-19 patients from becoming severely ill. So how ...

What Is Fluvoxamine? OCD Drug Could Be Used to Treat COVID On 3/8/21 at 9:49 AM EST An anti-depressant medication used to treat obsessive-compulsive disorder (OCD) may also be effective at treating some COVID cases, scientists say. The drug fluvoxamine, commonly sold under the brand name Luvox, has emerged as a candidate for early treatment of the disease, with studies suggesting it could prevent some people's symptoms progressing to the point of needing hospitalization. Fluvoxamine is a type of selective serotonin reuptake inhibitor (SSRI) which alters how chemicals used by nerves in the hum...

Small Study Suggests Antidepressant Fluvoxamine Could Treat COVID-19 Silvia Pittman © The Mighty Medication capsule on blue background An antidepressant already on the market could pave the way toward more affordable and accessible treatment for people with a symptomatic COVID-19 infection. A new clinical trial using the psychiatric drug fluvoxamine (brand name Luvox) showed promise in a Washington University trial in reducing serious outcomes for people with the virus. Researchers compared the course of illness for those who took the drug compared to a placebo group. Accor...